ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

NCAB Okays New System For Bypass Budget; FY 1983 Request $1.096 Billion DCCP Board Approves Payback System For Resources Now Free

June 5, 1981

NCAB Votes Down Effort to Delay CCOP RFA, Directs Subcommittee To Look Again A Program Components

February 12, 1982

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

Cancer Research Emphasis Grants (CREG) Offered As A New Way To Fund Contract Research Efforts

November 23, 1974

Indoor Tanning Industry Funded Author Of NEJM Review On Vitamin D Deficiency.

April 18, 2008